About Us
Who We Are
Our Values
Hypha’s aim is to deliver a first-class service to our clients. We are proud of our high standards and reputation in the industry, derived from our ethos for delivering top quality science in our areas of expertise.
We have a global reach and have worked with over a hundred companies worldwide to solve critical problems. We work collaboratively with clients to provide custom solutions that meet their needs.
Our History
Hypha was founded in 2004 by CEO Liam Evans and CSO Jonathan Steele, originally as a natural products drug discovery company focussing on novel compounds produced by Hypha’s collection of microbes.
Hypha quickly developed complementary technology in microbial biotransformation and purification expertise, building on existing skills in complex natural products chemistry. Since then, Hypha has expanded its technology base to become the go-to company for metabolite synthesis, complex purification and structural characterisation for pharma and agrochemical companies worldwide.
About Us
Delivering a first class service to our clients worldwide
Expertise
Hypha is your trusted global partner. We are go-to experts for metabolite solutions and have worked with many of the top pharma and agrochemical companies worldwide to deliver projects.
Flexibility
We will work with you to design a custom solution that meets your needs and which can be adapted in response to project milestones.
Service
We pride ourselves on our client focused approach. Our scientists will work with you to personally deliver your project.
News
Senior Purification Chemist Job
Q4 2023 Newsletter – Late-stage oxidation and deoxyfluorination
Metabolites that Matter – Ivermectin
Publications
Read about our publications in the fields of metabolite synthesis, biotransformation and natural products chemistry
Brochures
Access brochures on drug metabolite synthesis, Hypha’s one-stop metabolite shop and the PolyCYPs platform
Ready to begin? Our scientists are available to talk through your requirements
Hypha Discovery is a UK-based CRO supporting pharmaceutical and agrochemical companies worldwide through the production of metabolites and new derivatives of drugs and agrochemicals in discovery and development.